ImmunoPrecise Antibodies Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio
MarketScreener,
VICTORIA - Immunoprecise Antibodies Ltd. (NASDAQ: IPA) ('Immunoprecise' or 'IPA' or the 'Company'), an AI-driven biotherapeutic…